Article information
Full text is only aviable in PDF
Bibliografía
[1.]
F.E. Speizer, R. Doll, P. Heaf.
Observations on recent increase in mortality from asthma.
Br Med J, 1 (1968), pp. 335-339
[2.]
F.E. Speizer, R. Doll, P. Heaf.
Investigation into use of drugs preceding death from asthma.
Br Med J, 1 (1968), pp. 339-343
[3.]
P.D. Stolley.
Why the United States was spared an epidemic of deaths due to asthma.
Am Rev Respir Dis, 105 (1972), pp. 883-890
[5.]
S.F. Lanes, A.M. Walker.
Do pressurized bronchodilator aerosols cause death among asthmatics?.
Am J Epidemiol, 125 (1987), pp. 755-760
[6.]
J.M. Esdaile, A.R. Feinstein, R.I. Horwitz.
A repraisal of the United Kingdom epidemic of fatal asthma.
Arch Intern Med, 147 (1987), pp. 543-549
[7.]
J.D. Wilson, D.C. Sutherland, A.C. Thomas.
Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma?.
Lancet, 1 (1981), pp. 1.235-1.237
[8.]
R.T. Jackson, R. Beaglehole, H.H. Rea, et al.
Mortality from asthma: a new epidemic in New Zeeland.
Br Med J, 285 (1982), pp. 771-777
[9.]
I.W.B. Grant.
Asthma in New Zeeland.
Br Med J, 286 (1983), pp. 374-377
[10.]
G. Keating, E.A. Mitchell, R. Jackson, et al.
Trends in sales of drugs for asthma in New Zeeland. Australia and the United Kingdom, 1975-81.
Br Med J, 289 (1984), pp. 348-351
[11.]
M.R. Sears, H.H. Rea, R. Beaglehole, et al.
Asthma mortality in New Zeeland: a two year national study.
NZ Med J, 98 (1985), pp. 271-275
[12.]
M.R. Sears, R. Beaglehole.
Asthma morbidity and mortality: New Zeeland.
J Allergy Clin Immunol, 80 (1987), pp. 383-388
[13.]
J. Crane, N. Pearce, A. Flatt, et al.
Prescribed fenoterol and death from asthma in New Zeeland, 1981-1983: a case-control study.
Lancet, 1 (1989), pp. 917-922
[14.]
T.V. O’Donell, P. Holst, H.H. Rea, M.R. Sears.
Fenoterol and fatal asthma.
Lancet, 2 (1989), pp. 41
[15.]
N.E. Pearce, J. Grainger, M. Atkinson, et al.
Case-control study of prescribed fenoterol and death from asthma in New Zeeland, 1977-1981.
Thorax, 45 (1990), pp. 170-175
[16.]
J. Grainger, K. Woodman, N.E. Pearce, et al.
Prescribed fenoterol and death from asthma in New Zeeland 1981-1987: a further case-control study.
Thorax, 46 (1991), pp. 105
[17.]
M.R. Sears, D.R. Taylor, C.G. Print, et al.
Regular inhaled betaagonist treatment in bronchial asthma.
Lancet, 1 (1990), pp. 1.391-1.396
[18.]
W.O. Speizer, S. Suissa, P. Ernst, et al.
The use of B-agonists and the risk of death and near death from asthma.
N Engl J Med, 326 (1992), pp. 501-506
[19.]
Editorial.
Beta-2 agonists in asthma: relief, prevention, morbidity.
Lancet, 1 (1990), pp. 1.411-1.412
[20.]
B. Burrows, M.D. Lebowitz.
The B-agonists dilemma.
N Engl J Med, 326 (1992), pp. 560-561
[21.]
H.S. Nelson, S.J. Szefler, R.J. Martin.
Regular inhaled betaadrenergic agonists in the treatment of bronchial asthma:beneficial or detrimental?.
Am Rev Respir Dis, 144 (1991), pp. 249-250
Copyright © 1992. Sociedad Española de Neumología y Cirugía Torácica
